Ozempic Tied to 4x Higher Eye Stroke Risk in Diabetes Patients

[{"selector":"#anim-03663928-c889-4e9f-8487-9ac7ed47ac84 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-1.4210854715202004e-14%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-c4066a0c-b728-4dd0-8d1b-5d0c2c2a1b6f","keyframes":{"transform":["translate3d(-115.14196%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d9cee63c-32d6-4608-be1d-eace030f1392","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f68ed15f-80e9-4aa1-8f56-7f9ace1c6914","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-d3b7609e-b96b-4f1e-b529-6d87f14054cd","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Studies reveal that diabetes patients using Ozempic face over twice the risk of developing a rare but serious eye condition compared to those on other diabetes medications. Photo Source: Chemist4U (CC BY-SA 2.0)

[{"selector":"#anim-3cbf70e3-83ef-41a0-bed9-b92de751e0fb [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-2e8cdd2b-8866-445d-934c-d1822f240592","keyframes":{"transform":["translate3d(-115.14196%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-25269cc2-bd1a-43bc-b74e-c5fec22cf4fa","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a2c7a3f2-74aa-4a34-ba52-e3030bc5bf54","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-9898ed0e-1225-4e26-91da-4689573b34e6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] The condition supposedly induced by Ozempic, called non-arteritic anterior ischemic optic neuropathy (NAION), can cause sudden and irreversible vision loss. Photo Source: Ksenia Chernaya (Pexels)

[{"selector":"#anim-424b3e3a-3e56-4aea-9e44-df63bf2dfaf4 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-5.967509796740821%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-70d5c955-4275-4a62-ad6e-8575378656f9","keyframes":{"transform":["translate3d(-115.14196%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e32cbe50-046d-4504-8f86-6c75cf9d0c33","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c794b048-bab0-4089-b9b6-ff10d3d3547c","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-e04b60ce-88d4-43ae-8f6b-e715eb2789bc","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Research shows among the diabetes patients, those prescribed semaglutide experienced NAION at a rate more than four times higher than those who didn't receive the drug. Photo Source: NIH Image Gallery (CC BY-NC 2.0)

Although additional research is required, Dr Susan Mollan from University Hospitals Birmingham suggests GLP-1 drugs might cause paradoxical worsening of diabetic retinopathy.

[{"selector":"#anim-8b686f51-87fa-4936-97f2-9f12360741cf [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(7.016632132035987%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-69d27154-fd36-4051-a26d-bfcde98eebf2","keyframes":{"transform":["translate3d(-115.14196%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1e62eef7-d3d7-49b0-a5c9-ec47baf90649","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8a26e84d-ed6a-4840-b571-b972d2c7490a","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-222c24cc-8bbe-4da8-9687-f1eaf316d67a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Photo Source: Elliott Brown (CC BY 2.0)

Following the study's publication, Novo Nordisk's stock dropped 5.5% in Copenhagen trading, though shares remain up 8% this year.

[{"selector":"#anim-6f2a475a-d085-4327-907a-e77728834fd4 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-4eab42e5-2bdf-46f6-b521-18e06fdc7db5","keyframes":{"transform":["translate3d(-115.14196%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5a7256b2-a909-42e9-b2a0-5f25ed9ba14f","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e7a8bc0f-b660-477b-ba02-45b34385dac2","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-85c4114d-c6b5-495f-a38f-817c876f9818","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Photo Source: Siebuhr (CC BY-NC 2.0)

NAION is one of the leading causes of sudden blindness and affects up to 10 in every 100,000 people.

[{"selector":"#anim-949d3887-5241-4e3a-96af-c7bb2484950f [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-2.498437905244998%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-3e7b3e8b-ac9a-4494-8d82-61a56d46dfc2","keyframes":{"transform":["translate3d(-115.14196%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b83cdb64-51d0-4ccf-aa67-43386875229c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bfc3d1a7-bab2-499a-b7c1-0c8e60fe7242","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-b09b79c9-db18-4f15-8189-335fef40a1e3","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Photo Source: Tima Miroshnichenko (Pexels)

The study's findings for Wegovy, which shares semaglutide as its active ingredient with Ozempic, proved inconclusive due to limited patient data.

[{"selector":"#anim-605ce486-b1cb-4cc0-967b-94ab616d0250 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-3.272505372406254%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-7fe392ba-9302-45c4-a120-71ed0d3a932b","keyframes":{"transform":["translate3d(-115.14196%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-69cbb24b-ec57-46cf-95be-bcbac9c2a794","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-07b836d7-3853-4331-9c53-ea8ffedeee5d","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-2574d08e-29e0-4eaa-bf96-1831ae207d72","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Photo Source: Focal Foto (CC BY-NC 2.0)

[{"selector":"#anim-4eb254dc-4935-48de-85c2-9ffe2c83f69e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(-6.751827668158295%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-fe87e7bf-0228-4911-8c4f-3bc242df71c6","keyframes":{"transform":["translate3d(-115.14196%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e8a9b315-c238-4ecb-945d-1ef75278ba99","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9fccf513-e9cb-4e0e-ba26-f95fd74e0a04","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-5bba08ba-c549-47c4-876b-a4448fa75612","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Dr Rizzo advises patients who are concerned about the potential risks of semaglutide to consult their doctor, and warns those with pre-existing visual loss conditions to proceed with caution. Photo Source: Ksenia Chernaya (Pexels)

RSV Hits Infants Hard as Vaccines Target 14,000 Hospitalizations

[{"selector":"#anim-bdd7cf6d-3cfc-4677-9189-d671307f532c","keyframes":{"opacity":[1,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-f9d7a74d-a357-42bf-bbf8-f50b040594ae","keyframes":{"transform":["scale(3)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-d95c4077-696d-42a6-b2d4-f7535932ad1b","keyframes":{"transform":["translate3d(114.51104%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a2ffbbeb-302c-4223-b6c4-432ec7179ac7","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0fafe856-0e2c-4791-86d7-99685fce88c9","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] [{"selector":"#anim-e8af9f55-1c46-4801-a51e-2b14bcde13cd","keyframes":{"transform":["translate3d(-115.50632%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e5aa6f69-00eb-4484-b807-1de2b3e1925f","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c11ee401-357f-4c1b-aadf-a7a4ad9839d4","keyframes":{"transform":["scale(0.15)","scale(1)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"forwards"}] Learn more